Afghanistan

Date established	2002
Contact details	Marie Stopes International Afghanistan Street 1, House No. 3 Kart-1-Pawan District 3, Kabul Afghanistan Telephone: + 93 216 52 001 916 Email: fc.manager@msi-afg.org
Services offered	Family planning; health screening; HIV/STIs; maternal health; social marketing; young people
Number of clinics	15
Outreach / mobile services	Not yet
Social marketing products & brands	Condoms: Aramish Contraceptive pill: Feminyl Contraceptive injection: Aramish Femiject IUD: Aramish Femi-T
Major partners	Ministries of Education, Health, Religious Affairs & Women’s Affairs
Major donors	Government of Finland; Direct Relief International; Jersey Overseas Aid Commission

Click on red marker for clinic/programme information.
Click on map to close marker balloon.

Click on satelite for photo view,
and hybrid for photo and map view.

Highlights

secured consent from the Government for a five-fold increase in national outlets where women can access long term contraceptive services
introduced one of the country’s first condom brands, “Aramish” in 2002. Full year sales in 2006 reached 635,254
expanded the social marketing programme to include the brands Aramish Femiject (a 3 month injectable), Aramish Femi-T (an IUD) and Feminyl, (an oral contraceptive pill). The introduction of these brands has helped Marie Stopes International Afghanistan to double the number of couples it protects from unplanned pregnancies
published a document on family planning endorsed by the Ministry of Religious Affairs

Future plans

start mobile services to rural and remote communities
expand sterilisation services to more clinics
expand the number of clients receiving a long term family planning method (IUDs)

Research

Key statistics for Afghanistan
Source: UNFPA State of world population 2007
Total population (millions) (2007)	32.3
Average population growth rate (%) (2005 - 2010)	3.5
Projected population (millions) (2050)	97.3
Life expectancy (M / F)	47.2 / 47.7
Total fertility rate (2007)	7.11
% contraceptive prevalence: any method	5
% contraceptive prevalence: modern methods	4
Births per 1,000 women aged 15-19	113
% births with skills attendants	14
Maternal mortality ratio (per 100,000 live births)	1,900
Infant mortality total per 1,000 live births	143
Under 5 mortality (M / F)	234 / 240
HIV prevalence rate (%) (15-49) M / F	<0.1 / <0.1
Health expenditure public (% of GNP)	2.6